Folk sayings often mention that "a pandemic will only last for three years". Specifically, even a serious epidemic can be completely ended within three years.
The medical team led by Professor Huang Jianping (Lanzhou University) published a review article in a magazine, and predicted the epidemic trend of Omicron virus strain in COVID-19.
They said that COVID-19 is likely to end in June next year 165438+ 10, and the relevant assessment is based on the global epidemic prediction system, which has condensed the efforts of hundreds of scientific research academicians, and the monitoring accuracy rate is as high as 90%.
Professor Huang Jianping's team also clearly pointed out that prediction does not represent reality. After all, there are many variables in the future In case of "A Cheng Jin Yao", the epidemic may continue.
Good news came from the medical field: the relevant teams in China have developed COVID-19 therapeutic drugs, which have a strong ability to inhibit the virus.
In the middle of this month, good news spread frequently in the medical field, and relevant medical and health teams developed new drugs to treat COVID-19 infection.
At present, the new drug has been patented by the State Administration of Pharmaceutical Products, and the instructions clearly indicate a data: once the concentration of cepharanthine reaches 10 micromole/L, the times of inhibiting COVID-19 replication will exceed 10000 times.
Generally speaking, if there are 15000 cepharanthine in COVID-19, if 10 micromole/liter cepharanthine is used, the amount of cepharanthine will drop to single digits, and the probability of infection is very small.
According to relevant experimental data, cepharanthine is among the best in the list of inhibitory drugs in COVID-19. Even some western scholars agree with its medicinal efficacy, and think that the medicinal efficacy of cepharanthine has surpassed that of Parovi and Redixivir.
Perhaps one day in the future, the health care team can realize the combination of drugs and clinical practice, and effectively curb the replication and spread of COVID-19.
In addition, China is committed to researching COVID-19 vaccine to ensure the safety of residents to the greatest extent. With the increase of vaccination coverage, the mortality rate in COVID-19 will gradually decrease, and patients' lives will no longer be threatened.